Harpoon Therapeutics Inc.

NASDAQ: HARP · Real-Time Price · USD
23.01
0.02 (0.09%)
At close: Mar 08, 2024, 10:00 PM

Harpoon Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
31.91M 23.65M
Cost of Revenue
3.1M 2.65M
Gross Profit
28.82M 21.01M
Operating Income
-68.33M -116.75M
Interest Income
776K 240K
Pretax Income
-67.73M -116.72M
Net Income
-67.14M -166.44M
Selling & General & Admin
18.85M 18.33M
Research & Development
81.39M 72.12M
Other Expenses
-182K -210K
Operating Expenses
100.24M 90.45M
Interest Expense
n/a n/a
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
100.24M 90.45M
Income Tax Expense
-594K 49.71M
Shares Outstanding (Basic)
3.32M 3.23M
Shares Outstanding (Diluted)
3.32M 3.23M
EPS (Basic)
-20.24 -51.57
EPS (Diluted)
-20.24 -51.57
EBITDA
-65.97M -14.65M
EBIT
-68.33M -116.75M
Depreciation & Amortization
2.36M 102.1M